Association of IL-6, IL-10 and CXCL10 Serum Concentrations with Visceral Kaposi's Sarcoma in People Living with HIV/AIDS
Overview
Authors
Affiliations
Human gammaherpesvirus 8 (HHV-8) is the etiologic agent of Kaposi's sarcoma (KS), one of the most common cancers in people living with HIV/AIDS. It is believe that the course of both HIV and HHV-8 infection is associated with the imbalance of anti- and/or pro-inflammatory cytokines. Here, we evaluated the IL-6, TNF-α, IL-10, CCL2 and CXCL10 serum concentrations in HIV- and HIV/HHV-8 (without KS) individuals, and in patients with cutaneous or visceral AIDS-KS. Serum concentrations of IL-6, IL-10 and CXCL10 were significantly higher in the AIDS-KS group compared to HIV and HIV/HHV-8 individuals. Similarly, the concentrations of theses cytokines were higher in patients with visceral than in those with cutaneous AIDS-KS. The TNF-α concentration was significantly higher in the HIV group compared to HIV/HHV-8 (with and without KS) individuals, and CCL2 levels did not present significant difference among the groups. The HIV viral load was undetectable in all patients from the HIV and HIV/HHV-8 groups. On the other hand, in the AIDS-KS group, most patients had detectable HIV viral load. In this context, we believe that the cytokine levels in AIDS-KS may be result of a complex interaction between HIV, HHV-8 and immunity.
Arbune M, Padurariu-Covit M, Tiutiuca C, Mihailov R, Niculet E, Arbune A Trop Med Infect Dis. 2024; 9(2).
PMID: 38393136 PMC: 10892696. DOI: 10.3390/tropicalmed9020047.
Ramon-Luing L, Flores-Gonzalez J, Angel Garcia-Rojas L, Islas-Munoz B, Volkow-Fernandez P, Chavez-Galan L Clin Exp Immunol. 2023; 215(2):190-201.
PMID: 37904542 PMC: 10847826. DOI: 10.1093/cei/uxad115.
Alomari N, Totonchy J Viruses. 2022; 14(10).
PMID: 36298850 PMC: 9607942. DOI: 10.3390/v14102295.
The potential role of exosomal miRNAs and membrane proteins in acute HIV-infected people.
Li X, Wang W, Chen J, Xie B, Luo S, Chen D Front Immunol. 2022; 13:939504.
PMID: 36032099 PMC: 9411714. DOI: 10.3389/fimmu.2022.939504.
Li Y, Ren H, Cao J Int Immunopharmacol. 2022; 110:109005.
PMID: 35780641 PMC: 9236983. DOI: 10.1016/j.intimp.2022.109005.